Atherogenic Index Reduction and Weight Loss in Metabolic Syndrome Patients Treated with A Novel Pectin-Enriched Formulation of Bergamot Polyphenols.

Between-group comparison revealed a highly significant and dose-dependent decrease of HOMA-IR in the BPE-C low and high groups compared to Placebo group ( Figure 5 B), which corresponded to significant mean changes by −7.2% and −18.1%, with respect to the baseline values in low and high dose groups, respectively ( Figure 5 C).

also in 132,142 other papers